CN Patent
CN101516370A — 阿加曲班的无醇制剂
Assigned to Scidose LLC · Expires 2009-08-26 · 17y expired
What this patent protects
本发明提供了阿加曲班和相关化合物的水性制剂以及可重构制剂,其各自即使不完全地包含醇也是基本上不含醇。该制剂即使不是完全地不包含单糖、二糖和低聚糖也是基本上不含单糖、二糖和低聚糖。特别优选的实施方案是包含阿加曲班、乳糖酸和蛋氨酸的1毫克/毫升的现成即可给药型可注射剂型。
USPTO Abstract
本发明提供了阿加曲班和相关化合物的水性制剂以及可重构制剂,其各自即使不完全地包含醇也是基本上不含醇。该制剂即使不是完全地不包含单糖、二糖和低聚糖也是基本上不含单糖、二糖和低聚糖。特别优选的实施方案是包含阿加曲班、乳糖酸和蛋氨酸的1毫克/毫升的现成即可给药型可注射剂型。
Drugs covered by this patent
- Argatroban (ARGATROBAN) · Hikma Pharm Co Ltd
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.